Since ODYSSEY Outcomes demonstrated a reduction in adverse CV outcomes—as well as a decrease in associated, all-cause mortality—in post-ACS patients, what is your view on treating to push LDL-C levels to even lower levels than the 70 mg/dL threshold?

Since ODYSSEY Outcomes demonstrated a reduction in adverse CV outcomes—as well as a decrease in associated, all-cause mortality—in post-ACS patients, what is your view on treating to push LDL-C levels to even lower levels than the 70 mg/dL threshold?

CLICK HERE FOR CME CREDIT

Since ODYSSEY Outcomes demonstrated a reduction in adverse CV outcomes—as well as a decrease in associated, all-cause mortality—in post-ACS patients, what is your view on treating to push LDL-C levels to even lower levels than the 70 mg/dL threshold?

Created by

CMEducation Resources IQ&A Cardiovascular Intelligence Zone | The Medical and Preventive Cardiologist's Perspective

Presenter

R. Scott Wright, MD

R. Scott Wright, MD

Professor of Medicine Department of Cardiovascular Medicine Cardiovascular Division Mayo Clinic